The measurement of symptoms in young children with cancer: the validation of the memorial symptom assessment scale in children aged 7-12

Collins, John J., Devine, Tom D., Dick, Gina S., Johnson, Elizabeth A., Kilham, Henry A., Pinkerton, C. Ross, Stevens, M. M., Thaler, Howard T. and Portenoy, Russell K. (2002) The measurement of symptoms in young children with cancer: the validation of the memorial symptom assessment scale in children aged 7-12. Journal of Pain and Symptom Management, 23 1: 10-16. doi:10.1016/S0885-3924(01)00375-X


Author Collins, John J.
Devine, Tom D.
Dick, Gina S.
Johnson, Elizabeth A.
Kilham, Henry A.
Pinkerton, C. Ross
Stevens, M. M.
Thaler, Howard T.
Portenoy, Russell K.
Title The measurement of symptoms in young children with cancer: the validation of the memorial symptom assessment scale in children aged 7-12
Journal name Journal of Pain and Symptom Management   Check publisher's open access policy
ISSN 0885-3924
1873-6513
Publication date 2002-01
Year available 2001
Sub-type Article (original research)
DOI 10.1016/S0885-3924(01)00375-X
Open Access Status Not yet assessed
Volume 23
Issue 1
Start page 10
End page 16
Total pages 7
Place of publication Philadelphia, PA, United States
Publisher Elsevier
Language eng
Abstract Few studies have attempted to describe the experience of symptoms in young children with cancer. This is due, in part, to the lack of validated symptom assessment scales for this patient population. The objective of this study was to evaluate the reliability and validity of a revised Memorial Symptom Assessment Scale (MSAS) in patients aged 7-12 as an instrument for the assessment of symptoms in young children with cancer. The MSAS (7-12) was administered to 149 children (inpatients and outpatients) who were undergoing treatment at either the Royal Marsden NHS Trust, London, United Kingdom or The Children's Hospital at Westmead, Sydney, Australia. Validity was evaluated by comparison with the medical record, parental report, and concurrent assessment on visual analogue scales for selected symptoms. The data provide evidence of the reliability and validity of MSAS (7-12) and demonstrate that children with cancer as young as 7 years can report clinically relevant and consistent information about their symptom experience. Young children with cancer experience multiple symptoms. Approximately one-third had experienced lethargy and/or pain and/or insomnia during the 48 hours prior to the completion of MSAS (7-12). The completion rate for MSAS (7-12) was high and the majority of children completed the instrument in a short period of time and with little difficulty. The instrument appears to be age appropriate and may be helpful to older children unable to independently complete MSAS (10-18). Systematic symptom assessment may be useful in future epidemiological studies of symptoms and in cancer chemotherapy drug trials.
Keyword Cancer
Malignancy
Pediatrics
Children
Symptoms
Symptom distress
Q-Index Code C1
Q-Index Status Provisional Code
Institutional Status Non-UQ

Document type: Journal Article
Sub-type: Article (original research)
Collection: School of Medicine Publications
 
Versions
Version Filter Type
Citation counts: TR Web of Science Citation Count  Cited 95 times in Thomson Reuters Web of Science Article | Citations
Scopus Citation Count Cited 122 times in Scopus Article | Citations
Google Scholar Search Google Scholar
Created: Fri, 08 Jul 2016, 17:46:21 EST by System User on behalf of Learning and Research Services (UQ Library)